Qwest Corporation 7.00% Notes due 2052 | CTX

Qwest Corporation 7.00% Notes due 2052 Profile

  • Sector: Health Technology
  • Industry: Pharmaceuticals: Major
  • Employees: N/A

Crescita Therapeutics, Inc. engages in the provision of non-prescription skincare products. Its products include Pliaglis, Alyria, Laboratoire Dr Renaud, and Pro-Derm. It operates through the following business segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The Commercial Skincare segment manufactures and sells non-prescription skincare products. The Licensing and Royalties segment refers to the licensing related to its prescription product. The Manufacturing and Services segment relates to the sale of topical products and product development services. The company was founded on March 1, 2016 and is headquartered in Laval, Canada.

Qwest Corporation 7.00% Notes due 2052 in the news

Services We Offer

Need a custom stock scraper? Want to do some machine learning? We are here to help! Reach out to us!

Machine Learning

Custom Scraper

Automation

Consulting